Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

Drug development solutions

Whether your new therapy is a small molecule, a biological, a delivery device or a sophisticated gene or cell therapy, we provide science-driven solutions that accelerate and enhance your development. 

Operating from state-of-the-art facilities in the UK, Germany and the US, we have unrivalled breadth and depth in bioanalysis, CMC analytical and oligonucleotide therapeutics.​


Your samples are in safe hands. With one of the world’s largest bioanalytical centres, recognised for leadership in science and technology, LGC has comprehensive capabilities for pharmacokinetics, immunogenicity and biomarkers that span LC-MS/MS through to immunoassay, cell and molecular biology.  We routinely solve difficult method development challenges and, as your development progresses from discovery through to GLP preclinical and to GCP clinical trials; we have the capacity, rapid turnaround and logistics needed to support the largest, most complex protocols.

CMC analytical

With cGMP labs in the UK, Germany and US and a track record of success in regulatory audits, including the FDA, we have particular specialty in materials science and pharmaceutical analysis. We support the regulatory Chemistry, Manufacturing and Control (CMC) compliance of your drug substance and drug product through the complex challenges faced in drug development, solving issues at all stages of manufacture.

Oligonucleotide therapeutics

Our team at LGC Axolabs are internationally recognised experts in the growing field of oligonucleotide and nucleic acid therapeutics.  Underpinned by proprietary analytical and lipid delivery technologies we provide synthesis, discovery biology, medicinal chemistry, bioanalysis and CMC analysis support for all modalities; including siRNAs, ASOs, mRNA therapeutics and CRISPR/Cas.  Together with our cGMP manufacturing suite in California, we offer integrated, seamless support from discovery through to analytical and process development up to large-scale manufacture of investigational medicines for early clinical studies.

Partnering with LGC

We enjoy building strong partnerships and relish being viewed as part of your core team.  Sharing your passion, curiosity and dedication to solve the most demanding analytical and synthetic challenges our expert scientists help deliver your development project on time and to the highest scientific and quality standards.

To find out more and arrange to talk with our scientists about your project please contact us.

Forthcoming conferences and events

To find out where our drug development solutions team will be exhibiting next click here.